Prescriptions for antiulcer drugs in Australia: Volume, trends, and costs

British Medical Journal

Volumn 323, Issue 7325, 2001, Pages 1338-1339

  Westbrook, J I ^a   Duggan, A E ^b   McIntosh, J H ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT;

ARTICLE; AUSTRALIA; DRUG COST; DRUG MARKETING; ESOPHAGITIS; HUMAN; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; SCLERODERMA; ZOLLINGER ELLISON SYNDROME;

EID: 0035830044     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.323.7325.1338     Document Type: Article

References (5)

1. The top 200 drugs
2. Factors associated with consulting medical and non-medical health practitioners for dyspepsia: An Australian population-based study
3. Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia